Drilldown: Medicines

Codeine (1)

(multiple, generic dominant) (1)

Analgesic (1) · Opioid (1) · Prodrug (1)

None · 5-HT2A agonist · GABAA positive allosteric modulator · Monoamine releasing agent · CB1/CB2 agonist · Potent mu-opioid receptor agonist · Sodium channel blocker · Dopamine/norepinephrine reuptake inhibitor · GABAA potentiator; NMDA antagonist · Phenothiazine D2 antagonist · Potent 5-HT2A agonist · 5-HT1B/1D agonist · LSD analogue; 5-HT2A agonist · Mu-opioid receptor agonist · Muscarinic receptor antagonist · Prodrug of LSD; 5-HT2A agonist · Selective norepinephrine reuptake inhibitor · GABAA positive allosteric modulator (non-benzodiazepine) · GABAA potentiator and direct activator · Irreversible non-selective MAO inhibitor

Other values:

Search

Mild to moderate pain; cough suppression (low-dose). (1)

Adult: 15–60 mg every 4 hours as needed. (1)

Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

360 mg/day (1)

PO (only formulation marketed in the US). (1)

30–60 min (PO) (1)

4–6 hours (1)

2.5–3 hours (1)

~50% (variable, CYP2D6-dependent for analgesic effect). (1)

Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1)

US Schedule II (single-entity); Schedule III–V (combination products by content). (1)